{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:55:12Z","timestamp":1786996512337,"version":"build-2736575974"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/01555"],"award-info":[{"award-number":["PI20\/01555"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001455","name":"American Foundation for Suicide Prevention","doi-asserted-by":"publisher","award":["ECR-1-101-23"],"award-info":[{"award-number":["ECR-1-101-23"]}],"id":[{"id":"10.13039\/100001455","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","award":["31312"],"award-info":[{"award-number":["31312"]}],"id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["1R25MH129256-01A1"],"award-info":[{"award-number":["1R25MH129256-01A1"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006301","name":"Center for International Business Education and Research, University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.schres.2025.12.010","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T23:18:04Z","timestamp":1766445484000},"page":"35-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Use and outcomes of antipsychotic medications for delusional and paranoid personality disorders: A population-based study"],"prefix":"10.1016","volume":"288","author":[{"given":"Ana","family":"Gonzalo-deMiguel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Abascal-Peir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Mart\u00ednez-Al\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Baca-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"03","key":"10.1016\/j.schres.2025.12.010_bb0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4088\/JCP.v67n0317","article-title":"Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care","volume":"67","author":"Ascher-Svanum","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2025.12.010_bb0010","series-title":"StatPearls","article-title":"Paranoid personality disorder","author":"Jain","year":"2024"},{"issue":"6","key":"10.1016\/j.schres.2025.12.010_bb0015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1192\/bjp.184.6.509","article-title":"Non-adherence to antipsychotic medication regimens: associations with resource use and costs","volume":"184","author":"Knapp","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2025.12.010_bb0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.schres.2021.01.015","article-title":"Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients","volume":"228","author":"L\u00e4hteenvuo","year":"2021","journal-title":"Schizophr. Res."},{"issue":"Suppl. 5","key":"10.1016\/j.schres.2025.12.010_bb0025","first-page":"3","article-title":"Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia","volume":"67","author":"Leucht","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2025.12.010_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2021.11.003","article-title":"A proposal definition criteria for psychotic relapse: filling the gap for real-world studies","volume":"239","author":"Migoya-Borja","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2025.12.010_bb0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.schres.2024.07.040","article-title":"Antipsychotic use in a large community sample of patients with delusional disorder","volume":"271","author":"Miguel","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2025.12.010_bb0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.comppsych.2018.07.002","article-title":"Delusional disorder: the role of personality and emotions on delusional ideation","volume":"85","author":"Tonna","year":"2018","journal-title":"Compr. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099642500427X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099642500427X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:45:53Z","timestamp":1770335153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099642500427X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":8,"alternative-id":["S092099642500427X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2025.12.010","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use and outcomes of antipsychotic medications for delusional and paranoid personality disorders: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2025.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}